1. Kang SH, Park YH, Lee D, et al. The Cortical Neuroanatomy Related to Specific Neuropsychological Deficits in Alzheimer's Continuum. Dement Neurocogn Disord 2019;18:77-95.
2. Hardy JA, Higgins GA. Alzheimer's disease: the amyloid cascade hypothesis. Science 1992;256:184-185.
3. Bateman RJ, Xiong C, Benzinger TL, et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med 2012;367:795-804.
4. Wang MJ, Yi S, Han JY, et al. Oligomeric forms of amyloid-beta protein in plasma as a potential blood-based biomarker for Alzheimer's disease. Alzheimers Res Ther 2017;9:98.
5. Pyun JM, Kang MJ, Ryoo N, et al. Amyloid Metabolism and Amyloid-Targeting Blood-Based Biomarkers of Alzheimer's Disease. J Alzheimers Dis 2020;75:685-696.
6. An SSA, Lee BS, Yu JS, et al. Dynamic changes of oligomeric amyloid beta levels in plasma induced by spiked synthetic Abeta42. Alzheimers Res Ther 2017;9:86.
7. Youn YC, Lee BS, Kim GJ, et al. Blood Amyloid-beta Oligomerization as a Biomarker of Alzheimer's Disease: A Blinded Validation Study. J Alzheimers Dis 2020;75:493-499.
8. Pyun JM, Ryu JS, Lee R, et al. Plasma Amyloid-beta Oligomerization Tendency Predicts Amyloid PET Positivity. Clin Interv Aging 2021;16:749-755.
9. Youn YC, Kang S, Suh J, et al. Blood amyloid-beta oligomerization associated with neurodegeneration of Alzheimer's disease. Alzheimers Res Ther 2019;11:40.
10. McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:263-269.
11. Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:270-279.
12. Jessen F. Subjective and objective cognitive decline at the pre-dementia stage of Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci 2014;264 Suppl 1:S3-7.
13. Jessen F, Amariglio RE, van Boxtel M, et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease. Alzheimers Dement 2014;10:844-852.
14. Rampasek L, Goldenberg A. TensorFlow: Biology's Gateway to Deep Learning? Cell Syst 2016;2:12-14.
15. Ying X. An Overview of Overfitting and its Solutions. Journal of Physics: Conference Series 2019;1168:022022.
16. Chicco D. Ten quick tips for machine learning in computational biology. BioData Min 2017;10:35.
17. Kang MJ, Kim SY, Na DL, et al. Prediction of cognitive impairment via deep learning trained with multi-center neuropsychological test data. BMC Med Inform Decis Mak 2019;19:231.